Astria Therapeutics, Inc. Long-Term Debt, Maturity, Year Two
Astria Therapeutics, Inc. had Long-Term Debt, Maturity, Year Two of $2.50 million as of 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2017-11-09
- 2017-09-30: Long-Term Debt, Maturity, Year Two $2.50M.
- 2017-06-30: Long-Term Debt, Maturity, Year Two $2.50M.
- 2017-03-31: Long-Term Debt, Maturity, Year Two $2.50M.
- 2016-12-31: Long-Term Debt, Maturity, Year Two $2.50M.
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2017-09-30 | $2.50M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $2.50M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $2.50M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $2.50M 10-K · filed 2017-03-16 |
| 2016-09-30 | $3.33M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $3.33M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $3.33M 10-Q · filed 2016-05-12 |
| 2015-09-30 | $3.33M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $3.33M 10-Q · filed 2015-08-13 |
| 2014-12-31 | $1.67M 10-Q · filed 2015-11-12 |